000			01844 a2200553 4500
005			20250516152253.0
264		0	_c20140402
008			201404s 0 0 eng d
022			_a1872-6968
024	7		_a10.1016/j.clineuro.2013.04.017 _2doi
040			_aNLM _beng _cNLM
100	1		_aBloch, Orin
245	0	0	_aDisseminated progression of glioblastoma after treatment with bevacizumab. _h[electronic resource]
260			_bClinical neurology and neurosurgery _cSep 2013
300			_a1795-801 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aBevacizumab
650	0	4	_aBrain Neoplasms _xdrug therapy
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGlioblastoma _xdrug therapy
650	0	4	_aHumans
650	0	4	_aKarnofsky Performance Status
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local
650	0	4	_aNeoplasm, Residual
650	0	4	_aNeurosurgical Procedures
650	0	4	_aRetrospective Studies
650	0	4	_aSurvival Analysis
650	0	4	_aYoung Adult
700	1		_aSafaee, Michael
700	1		_aSun, Matthew Z
700	1		_aButowski, Nicholas A
700	1		_aMcDermott, Michael W
700	1		_aBerger, Mitchel S
700	1		_aAghi, Manish K
700	1		_aParsa, Andrew T
773	0		_tClinical neurology and neurosurgery _gvol. 115 _gno. 9 _gp. 1795-801
856	4	0	_uhttps://doi.org/10.1016/j.clineuro.2013.04.017 _zAvailable from publisher's website
999			_c22779683 _d22779683